Sort by 
Manufacturing momentum holds but cost headwinds tighten margins
Irish manufacturing continued to expand in July, with strong demand driving production and new orders.
Investment targets medical innovation in high-growth medtech space
Graham Partners has acquired Irish-headquartered Smithstown Light Engineering (SLE), signalling strong momentum in the outsourced medical device manufacturing market.
AMIC Project Poised to Transform Northern Ireland’s Manufacturing Sector
The £98m Advanced Manufacturing Innovation Centre (AMIC), backed by the £930m Belfast Region City Deal, is expected to create 1,500 jobs and support 300 apprentices by 2050.
Irish Manufacturing Grows for 7th Consecutive Month Despite Tariff Pressures
Ireland’s manufacturing sector continued to expand in July, defying global trends and rising input costs, according to AIB’s latest PMI report.
Manufacturing momentum
This ongoing evolution highlights how Northern Ireland's manufacturing sector is not just surviving, but thriving.
Manufacturing Excellence Awards set sights on 2026
The 2025 awards may be over, but preparations for 2026 are underway. Expect another year of innovation, recognition and insight across the sector.
CRH targets green growth with €2.1bn US cement alternatives deal
CRH has agreed to acquire Utah-based Eco Material Technologies for $2.1bn (€1.73bn) in a major step toward low-carbon construction in the US.
Northern Irish frontline workers lead UK in trust for AI and automation
Frontline workers in Northern Ireland are the most trusting in the UK when it comes to AI and automation, with 75% expressing confidence in new technologies to improve safety at work—more than double the UK average.
Ireland launches 'Silicon Island' strategy to lead global semiconductor growth
Ireland has launched its ambitious Silicon Island strategy to establish itself as a global semiconductor powerhouse.
LIfT BioSciences secures €12m Irish grant to advance first-in-human trial of breakthrough cancer therapy
UK-Irish biotech LIfT BioSciences has secured a record €12 million grant from Ireland’s Disruptive Technologies Innovation Fund to launch its first-in-human clinical trial of Immuno-Modulatory Alpha Neutrophils (IMANs)—a novel cell therapy targeting treatment-resistant solid tumours.
Discover What's Happening
Explore our newsletters
Join our Newsletter to receive the latest industry trends, expert tips, and exclusive insights delivered straight to your inbox!
.png)
